Summary
The present study was carried out in an homogenous group of 49 untreated hypertensive patients, all aged 45 years. Diastolic blood pressure was equal to or greater than 110 mmHg in successive measurements; eleven patients were classified as WHO group II, and the others as WHO group I. An initial placebo period of 3 weeks was followed by cyclothiazide medication with a good response in 6 patients. The remaining patients were given either clonidine or practolol, and by adjustment of the dose a good response was obtained in 31 patients. In these cases the treatment was exchanged after 6 weeks. The antihypertensive effect of relatively small doses of clonidine was equal to that of practolol. Since completion of the study practolol has been withdrawn because of the emergence of long term toxic effects. In 12 cases, hydralazine had to be added to obtain a satisfactory response. Mild side-effects were common, especially at the beginning of clonidine treatment, but they did not necessitate discontinuation of treatment. Further comparative studies of clonidine and beta-blockers should be carried out and more experience with the combination of clonidine and vasodilators in the treatment of hypertension is necessary.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brod, J., Horbach, H., Just, H., Rosenthal, J., Nicolescu, R.: Acute effect of clonidine on central and peripheral haemodynamics and plasma renin activity. Europ. J. clin. Pharmacol.4, 107–114 (1972)
Felix, R.H., Ive, F.A., Dahl, M.G.C.: Cutaneous and ocular reactions to practolol. Brit. Med. J.1974/4, 321–324
Frotscher, U., Wilbrandt, R., Piel, W., Freyland, M.D., Messerschmidt, W.: Der Einfluß einer Kombinationstherapie mit Adelphan-Esidrix und Clonidin auf Blutdruck und Nierenfunktion bei renaler Hypertonie. Dtsch. Med. Wschr.96, 1380–1383 (1971)
Fyhrquist, F., Kurppa, K., Huuskonen, M.: Plasma renin activity, blood pressure and sodium excretion during treatment with clonidine. Acta Med. Scand.197, 457–461 (1975)
Green, K.G.: Improvement in prognosis of myocardial infarction by long-term beta-adrenoceptor blockade using practolol. Brit. Med. J.1975/3, 735–740
Hansson, L., Olander, R., Åberg, H., Malmcrona, R., Westerlund, A.: Treatment of hypertension with propranolol and hydralazine. Acta med. scand.190, 531–534 (1971)
Hoobler, S.W., Sagastume, E.: Clonidine hydrochloride in the treatment of hypertension. Amer. J. Cardiol.28, 67–73 (1971)
Kincaid-Smith, P., Macdonald, I.M., Hua, A., Laver, M.C., Fang, P.: Changing concepts in the management of hypertension. Med. J. Austral.1, 327–332 (1975)
Koch-Weser, J.: Individualization of antihypertensive drug therapy. Med. Clin. North Amer.58, 1027–1036 (1974)
Kosman, M.E.: Evaluation of clonidine hydrochloride (Catapres). J. Amer. med. Ass.233, 174–176 (1975)
Mroczek, W.J., Davidov, M., Finnerty, F.A.: Prolonged treatment with clonidine: comparative antihypertensive effects alone and with a diuretic agent. Amer. J. Cardiol.30, 536–541 (1972)
Mroczek, W.J., Leibel, B.A., Finnerty, F.A.: Comparison of clonidine and methyldopa in hypertensive patients receiving a diuretic. Amer. J. Cardiol.29, 712–717 (1972)
Pitkäjärvi, T., Ala-Laurila, P., Torsti, P., Ruosteenoja, R.: The use of clonidine and practolol in the treatment of hypertension. Ann. Clin. Res.8, 48–54 (1976)
Raftos, J., Bauer, G.E., Levis, R.G., Stokes, G.S., Mitchell, A.S., Young, A.A., Maclachlan, I: Clonidine in the treatment of severe hypertension. Med. J. Austral.1, 786–793 (1973)
Rudhardt, M., Boymond, P., Fabre, J.: La micronisation accroit — elle l'efficacité des salidiurétiques? Etude galénique et clinique de la cyclothiazide micronisée et non micronisée. Schweiz. Med. Wschr.96, 542–546 (1966)
Sannerstedt, R., Stenberg, J., Johnsson, G., Werkö, L.: Hemodynamic interference of alprenolol with dihydralazine in normal and hypertensive man. Amer. J. Cardiol.28, 316–320 (1971)
Schvartz, N., Torosdag, S., Fertig, H., Fletcher, L., Quan, R.B.F., Schwartz, M.S., Bryant, J.M.: Cyclothiazide, a new diuretic-antihypertensive drug. Curr. Ther. Res.4, 437–440 (1962)
Shand, D.G.: Individualization of propranolol therapy. Med. Clin. North Amer.58, 1063–1069 (1974)
Siitonen, L., Jänne, J., Keyriläinen, O., Koskinen, P., Leskinen, O., Pitkäjärvi, T., Reinikainen, M.: Hydralazine and beta-adrenergic blockade in the treatment of hypertension. Ann. Clin. Res.6, 341–346 (1974)
Stokes, G.S., Weber, M.A.: Prazosin: Preliminary report and comparative studies with other antihypertensive agents. Brit. Med. J.1974/2, 298–300
Sundquist, H., Anttila, M., Arstila, M.: Antihypertensive effects of practolol and sotalol. Clin. Pharmacol. Ther.16, 465–472 (1974)
Swartz, C., Seller, R.H., Fuchs, M., Spitzer, S., Onesti, G., Brest, A.N., Moyer, J.H.: The clinical pharmacology of cyclothiazide. Amer. J. Med. Sci.245, 573–581 (1963)
Zacest, R., Gilmore, E., Koch-Weser, J.: Treatment of essential hypertension by combined vasodilatation and adrenergic blockade. Clin. Pharmacol. Ther.12, 305 (1971)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pitkäjärvi, T., Ala-Laurila, P., Ruosteenoja, R. et al. Treatment of hypertension successively with a diuretic, clonidine or a beta-blocking agent and hydralazine. Eur J Clin Pharmacol 12, 161–165 (1977). https://doi.org/10.1007/BF00609853
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609853